alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Pension Benefit Guaranty Corporation

          - 29 CFR Part 4022

# AGENCY:

Pension Benefit Guaranty Corporation.

# ACTION:

Final rule; correction.

# SUMMARY:

                        The Pension Benefit Guaranty Corporation published in the                         **Federal Register**                         of April 15, 2009, a final rule informing the public of the interest rates and assumptions to be used under certain Pension Benefit Guaranty Corporation regulations. This document corrects an inadvertent error in that final rule.                    

# DATES:

Effective May 1, 2009.

# FOR FURTHER INFORMATION CONTACT:

Catherine B. Klion, Attorney, Legislative and Regulatory Department, Pension Benefit Guaranty Corporation, 1200 K Street, NW., Washington, DC 20005, 202-326-4024. (TTY/TDD users may call the Federal relay service toll-free at 1-800-877-8339 and ask to be connected to 202-326-4024.)

# SUPPLEMENTARY INFORMATION:

                    The Pension Benefit Guaranty Corporation published a document in the April 15, 2009,                     **Federal Register**                     (74 FR 17395),  informing the public of the interest rates and assumptions to be used under certain Pension Benefit Guaranty Corporation regulations. This document corrects an inadvertent error in that final rule.                

In FR Doc. E9-8674, published on April 15, 2009 (74 FR 17395), make the following corrections.

## Appendix B to Part 4022—[Corrected]

1. On page 17396, in the table for Appendix B to Part 4022, under “Immediate annuity rate (percent)”, remove the figure “3.25”, and add, in its place, “3.50”. 

## Appendix C to Part 4022—[Corrected]

2. On page 17396, in the table for Appendix C to Part 4022, under “Immediate annuity rate (percent)”, remove the figure “3.25”, and add, in its place, “3.50”. 

Issued in Washington, DC, on this 16th day of April 2009.

Vincent K. Snowbarger,

Acting Director, Pension Benefit Guaranty Corporation.

[FR Doc. E9-9212 Filed 4-21-09; 8:45 am]

BILLING CODE 7709-01-P
## SERVED: February 3, 2014
U.S. DEPARTMENT OF TRANSPORTATION OFFICE OF HEARINGS

WASHINGTON, DC
IN THE MATTER OF 

### AERO MICRONESIA FAA DOCKETNO. [TO BE ASSIGNED] (Civil Penalty Action) FDMS NO. FAA-2012- 0468 

### ORDER DENYING MOTION FOR DECISION The Federal Aviation Administration (hereinafter "Complainant") filed a motion for Decision dated September 13, 2013. Aero Micronesia (hereinafter "Respondent") filed a rebuttal dated December 6, 2013. Respondent's headquarters is Danville, CA. WHEREFORE, Complainant's Motion for Decision and Respondent's Rebuttal to Motion for Decisionhaving beenread and considered, itbe and is hereby ORDERED, as follows:1. Complainant's Motion for Decision is DENIED. 2. The parties should anticipate this matterbeing set for hearing during May or June 2014. 3. Theparties should advise the court on orbefore February 24, 2014, whether they would prefervenue to be inthe Los Angeles, CA area, San Francisco or Honolulu.4. All future communications shouldbe directed to the undersigned at: Richard C. Goodwin, U.S. Administrative Law Judge Office ofHearings, Attn: Room E11-310 U.S. Department ofTransportation 1200NewJersey, S.E. Washington, D.C. 20590 (Richard.Goodwin@dot.gov) Administrative matters should be directed to PatriciaMatthews, Staff Assistant (202) 366.:5121 (Patricia.Matthews@dot.gov)

Richard C. Goodwin U.S. Administrative Law Judge Attachment

- Service List

2

L__
_______________________ -CORRECTED SERVICE LIST ORIGINAL & ONE COPY Federal Aviation Administration 800 Independence Avenue, S.W. Washington, DC 20591 Attention: Hearing Docket Clerk, AGC--430 Wilbur Wright Building-Suite 2W10007 ONE COPY David M. Kirstein and Lyndsey M. Grunewald Kirstein & Young, PLLC, Respondent's Counsel 1750 K Street, N.W., Suite 200 Washington, DC 20006 TEL: 202-331-3348 FAX: 202-331-3933 Michael R. Quinn, President Aero Micronesia, Inc. dbaAsiaPacific Airlines, Inc., Respondent 156 Diablo Road, Suite 203
-· - ·· · ·Danville, CA 94526 TEL: 925-362-4430 FAX: 925-362-4432 Don Bobertz, Complainant's Counsel Office ofthe Regional Counsel, AWP-7 PO Box 92007 Los Angeles, CA 90009-2007 TEL: 310-725-3454 FAX: 310-725-6816 The Honorable Richard C. Goodwin,AdministrativeLawJudge Office ofHearings, M-20 U.S. Department ofTransportation 1200NewJersey Avenue, S.E. (Ell-310) Washington, DC 20590 TEL: 202-366-2139 Attorney-Advisor 202-366-5121 StaffAssistant FAX: 202-366-7536 FDMS NO. FAA-2012-0468 (Civil Penalty Action)

7 Service was by U.S. Mail. For service in person orby expedited courier, use the following address: Federal Aviation Administration, 600 Independence Avenue, S.W., Wilbur Wright Building-Suite 2W1000, Washington, DC 20591; Attention: Hearing Docket Clerk, AGC-430.3

'-------------------

---
Electronically Filed

Intermediate Court of Appeals

CAAP-13-0000394

30-MAY-2014

08:21 AM
II 

112TH CONGRESS 

2D SESSION S. 2822 

To extend the suspension of duty on p-Aminobenzamide (4-aminobenzamide). 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. KERRY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the suspension of duty on p-Aminobenzamide (4- 

aminobenzamide). 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. P-AMINOBENZAMIDE (4-AMINOBENZAMIDE). 

4 (a) IN GENERAL.—Heading 9902.25.13 of the Har5 monized Tariff Schedule of the United States (relating to 

6 p-Aminobenzamide (4-aminobenzamide)) is amended by 

7 striking the date in the effective period column and insert8 ing ‘‘12/31/2015’’. 

9 (b) EFFECTIVE DATE.—The amendment made by 

10 this section applies to goods entered, or withdrawn from 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 2822 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS
Exhibit 13.1

Annual Certification

Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Santander UK plc (the Company), does hereby certify, to such officers knowledge, that:

The Annual Report on Form 20-F for the year ended 31 December 2011 (the Form 20-F) of the Company fully complies
with the requirements of section 13(a) and 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                     |  |  |  |     |  |                        
|-------------------- |  |  |  | --- |  | -----------------------
|                     |  |  | 
|Dated: 15 March 2012 |  |  |  | By: |  | /s/ Ana Botín          
|                     |  |  |  |     |  | Ana Botín              
|                     |  |  |  |     |  | Chief Executive Officer



|                     |  |  |  |     |  |                        
|-------------------- |  |  |  | --- |  | -----------------------
|                     |  |  | 
|Dated: 15 March 2012 |  |  |  | By: |  | /s/ Stephen Jones      
|                     |  |  |  |     |  | Stephen Jones          
|                     |  |  |  |     |  | Chief Financial Officer
II 

112TH CONGRESS 

2D SESSION S. 3142 

To extend the temporary suspension of duty on Hostapur SAS. 

IN THE SENATE OF THE UNITED STATES 

MAY 10, 2012 

Mrs. HAGAN introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on Hostapur 

SAS. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. HOSTAPUR SAS. 

4 (a) IN GENERAL.—Heading 9902.34.01 of the Har5 monized Tariff Schedule of the United States (relating to 

6 petroleum sulfonic acids, sodium salts) is amended by 

7 striking the date in the effective period column and insert8 ing ‘‘12/31/2015’’. 

9 (b) EFFECTIVE DATE.—The amendment made by 

10 subsection (a) applies with respect to goods entered, or 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 3142 IS

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 21-7094

JONATHAN JAMES NEWELL,

Plaintiff - Appellant,

v.

NORTH CAROLINA INDUSTRIAL COMMISSION; PHILIP A. BADDOUR; 

KIMBERLY D. GRANDE; ERIK A. HOOKS; TODD ISHEE; KENNETH 

BEAVER,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern District of North Carolina, at 

Raleigh. Richard E. Myers, II, Chief District Judge. (5:20-ct-03366-M)

Submitted: November 1, 2022 Decided: February 1, 2023

Before GREGORY, Chief Judge, RICHARDSON and RUSHING, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Jonathan James Newell, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.

USCA4 Appeal: 21-7094 Doc: 11 Filed: 02/01/2023 Pg: 1 of 2
2

PER CURIAM:

Jonathan James Newell appeals the district court’s order dismissing without 

prejudice his 42 U.S.C. § 1983 complaint for failure to state a claim on which relief may 

be granted under 28 U.S.C. § 1915(e)(2)(b)(ii).

∗ We have reviewed the record and find no 

reversible error. Accordingly, we affirm the district court’s judgment. Newell v. N.C. 

Indus. Comm’n, No. 5:20-ct-03366-M (E.D.N.C. July 16, 2021). We deny Newell’s

petition for an initial hearing en banc. We dispense with oral argument because the facts 

and legal contentions are adequately presented in the materials before this court and 

argument would not aid the decisional process.

AFFIRMED

∗ The district court’s dismissal without prejudice is a final, appealable order because 

the district court dismissed the complaint “without granting leave to amend.” Britt v. 

DeJoy, 45 F.4th 790, 791, 798 (4th Cir. 2022) (en banc) (published order).

USCA4 Appeal: 21-7094 Doc: 11 Filed: 02/01/2023 Pg: 2 of 2
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2593 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2593

      To extend the suspension of duty on trifloxysulfuron-sodium.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Mr. Carper (for himself and Mr. Coons) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
      To extend the suspension of duty on trifloxysulfuron-sodium.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TRIFLOXYSULFURON-SODIUM.

    (a) In General.--Heading 9902.13.32 of the Harmonized Tariff 
Schedule of the United States (relating to trifloxysulfuron-sodium) is 
amended by striking the date in the effective period column and 
inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2966 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2966

           To suspend temporarily the duty on Allyl Heptoate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
           To suspend temporarily the duty on Allyl Heptoate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALLYL HEPTOATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Heptanoic acid      Free         No change        No change        On or before 12/  ''.
                        (CAS No. 142-19-                                                   31/2015.......
                        8) (provided for
                        in subheading
                        2915.90.5000)....

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
[Federal Register Volume 74, Number 78 (Friday, April 24, 2009)]
[Notices]
[Page 18730]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9251]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Deafness and Other Communication Disorders; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Deafness and Other 
Communication. Disorders Special Emphasis Panel. Investigator-
Initiated Clinical Trials.
    Date: May 12, 2009.
    Time: 12 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6120 Executive Blvd., 
Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Christine A. Livingston, PhD, Scientific Review 
Officer, Division of Extramural Activities, National Institutes of 
Health/NIDCD, 6120 Executive Blvd.--MSC 7180, Bethesda, MD 20892. 
(301) 496-8683. <a href="/cdn-cgi/l/email-protection#167a7f607f78716575567b777f7a38787f7e38717960"><span class="__cf_email__" data-cfemail="0965607f60676e7a6a496468606527676061276e667f">[email protected]</span></a>.

    Reviewers confirmed late.
    Name of Committee: National Institute on Deafness and Other 
Communication. Disorders Special Emphasis Panel. Chemical Senses 
Clinical Research.
    Date: May 19, 2009.
    Time: 12:30 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6120 Executive Blvd., 
Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Sheo Singh, PhD, Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Activities, 
Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD 
20892. 301-496-8683. <a href="/cdn-cgi/l/email-protection#7d0e14131a150e3d1314191e1953131415531a120b"><span class="__cf_email__" data-cfemail="1063797e777863507e797473743e7e79783e777f66">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.173, 
Biological Research Related to Deafness and Communicative Disorders, 
National Institutes of Health, HHS)

    Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-9251 Filed 4-23-09; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The undersigned, Colman Cheng, the Chief Financial Officer and
Treasurer of CHINA NUTRIFRUIT GROUP LIMITED (the Company), DOES HEREBY CERTIFY
that: 1. The Companys Quarterly Report on Form 10-Q for the quarter
ended December 31, 2008 (the "Report"), fully complies with the requirements of
Section 13(a) of the Securities Exchange Act of 1934; and 2. Information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the
Company. IN WITNESS WHEREOF, each of the undersigned has executed this
statement this 17th day of February, 2009. /s/ Colman
ChengColman ChengChief Financial Officer and Treasurer (Principal
Financial Officer) A signed original of this written statement required by Section
906 has been provided to China Nutrifruit Group Limited and will be retained by
China Nutrifruit Group Limited and furnished to the Securities and Exchange
Commission or its staff upon request. The forgoing certification is being furnished to the Securities
and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being
filed for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, and is not to be incorporated by reference into any filing of the
Company, whether made before or after the date hereof, regardless of any general
incorporation language in such filing.
exv10w51



 





Exhibit 10.51




Summary of 2008 Named Executive Performance Targets under Variable Pay Program




The variable pay program is an annual cash incentive program and provides all of our employees,
including named executive officers, the opportunity to earn cash incentive bonuses based on the
achievement of specific company or function performance goals.



Our board of directors approved overall corporate performance targets for 2008 that are designed to
motivate the achievement of the objectives set out in our business plan. Unlike 2007, the 2008
performance targets for our named executives do not include individual performance objectives.
Therefore, named executives’ variable pay in 2008 will depend entirely on corporate performance.
Each performance metric has a weight within the plan, and the sum of the weights is 100%.



     There are three performance levels established for the goals: Threshold, Target, and Stretch,
defined below:



	 	 	 	 	 
	Threshold

	 	•	 	the minimum level of performance necessary to receive a
payout
	 

	 	•	 	there is no payout for performance below Threshold
	 

	 	•	 	we believe there is an 80% probability of attaining at least
Threshold performance measures
	 
	 	 	 	 
	Target

	 	•	 	the expected level of performance
	 

	 	•	 	we believe there is a good probability of attaining target
performance measures
	 
	 	 	 	 
	Stretch

	 	•	 	performance beyond Target
	 

	 	•	 	we believe there is a 20% probability of attaining Stretch
performance measures






For 2008, all of our executive officers, except our Chief Executive Officer, have variable pay
program payout ranges as a percentage of base salary of 20% at Threshold, 40% at Target and 70% at
Stretch. The 2008 variable pay program payout range for our Chief Executive Officer is being
reviewed by our Human Resources and Compensation Committee and has not yet been determined.



Each component of the 2008 Plan allows for under performance (Threshold), on target performance
(Target) and over performance (Stretch). The minimum payment is 0% for performance below
threshold.



Corporate Performance Targets.   Our 2008 corporate performance targets and weightings for named
executive officers are:




	•	 	40% Earnings Target
	•	 	25% New Product Development Target
	•	 	15% Business Development Target
	•	 	10% Intellectual Property Target
	•	 	10% Investor Relations Target





Our board of directors can exercise discretion to pay compensation even if performance does not
meet our performance goals.
exv4w7w6






EXHIBIT 4.7.6




Sixth Joinder to the Registration Rights Agreement




     With respect to the Registration Rights Agreement, (the “Registration Rights Agreement”) dated
as of November 5, 2009, among Reynolds Group Issuer LLC, a Delaware limited liability company (the
“US Issuer I”), Reynolds Group Issuer Inc., a Delaware corporation (the “US Issuer II”), Reynolds
Group Issuer (Luxembourg) S.A., a société anonyme (limited liability company) organized under the
laws of Luxembourg (the “Luxembourg Issuer” and, together with US Issuer I and US Issuer II, the
“Issuers”), the Closing Date Guarantors and Credit Suisse Securities (USA) LLC, as representative
of the Initial Purchasers, for good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, each of the signatories hereto (i) hereby agrees to become a party to
the Registration Rights Agreement as a Guarantor with the same force and effect as if originally
named a Closing Date Guarantor therein and (ii) without limiting the generality of the foregoing,
assumes all of the rights and obligations of the Guarantors under the Registration Rights
Agreement, in each case, as of the time of delivery of this Joinder on March 29, 2010, as though it
had entered into the Registration Rights Agreement on November 5, 2009. The obligations assumed by
the Guarantors under this Joinder shall be joint and several obligations. Capitalized terms used
but not defined in this Joinder shall have the meanings given to such terms in the Registration
Rights Agreement.



 









 




IN WITNESS WHEREOF, the parties hereto have executed this agreement this 30th day of
March 2010.




	 	 	 	 	 
	 	SIG BEVERAGES BRASIL LTDA.

 	 
	 	By  	/s/ Felix Colas Morea
 	 
	 	 	Title: Manager 	 
	 	 	 	 
	 	SIG COMBIBLOC DO BRASIL LTDA.

 	 
	 	By  	/s/ Edimara Iansen Wieczorek
 	 
	 	 	Title: Legal Manager 	 
	 	 	 	 
	 	By  	/s/ Ricardo Lanca Rodriguez
 	 
	 	 	Title: General Manager 	 
	 	 	 	 
	 



Sixth Joinder to the Registration Rights Agreement